Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials
Joline Ingels, Laurenz De Cock, Rupert Laurenz Mayer, Pam Devreker, Karin Weening, Kelly Heyns, Nele Lootens, Saskia De Smet, Marieke Brusseel, Stijn De Munter, Melissa Pille, Lore Billiet, Glenn Goetgeluk, Sarah Bonte, Hanne Jansen, Sandra Van Lint, Georges Leclercq, Tom Taghon, Björn Menten, Karim Y. Vermaelen, Francis Impens, Bart Vandekerckhove
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1016/j.jcyt.2021.08.005
- Published
- Oct 22, 2021
- Venue
- Cytotherapy
- DOI
- 10.1016/j.jcyt.2021.08.005
- PubMed
- 34696961
- Categories
- Immunotherapy and Immune Responses
- License
- cc-by-nc-nd
- Provenance
- openalex